SCHEMBL30767862

SCHEMBL30767862

CCN(CC)c1ccc(C(=O)Nc2cccc3c2OCO3)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
POLB P06746 3/20 0.56
GHSR Q92847 1/20 0.47
ALDH1A1 P00352 5/20 0.46
LMNA P02545 4/20 0.46
MAPK1 P28482 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
PTGS2 P35354 1/20 0.46
MEN1 O00255 2/20 0.45
CYP1A2 P05177 3/20 0.44
CYP2C19 P33261 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP3A4 P08684 2/20 0.44
GFER P55789 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ABCB1 P08183 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30767873 0.86 PTGS2 (0.49) KMT2ANPC1RAB9APOLBALDH1A1
SCHEMBL30767870 0.81 PTGS2 (0.56) KMT2ANPC1RAB9APOLBALDH1A1
SCHEMBL30767871 0.80 ALDH1A1 (0.58) KMT2ANPC1RAB9APOLBALDH1A1
SCHEMBL30767861 0.80 RAB9A (0.52) KMT2ANPC1RAB9APOLBALDH1A1
SCHEMBL30767865 0.79 F10 (0.61) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL30767858 0.78 PTGS1 (0.53) KMT2ANPC1RAB9APOLBALDH1A1
SCHEMBL29864676 0.77 PTGS2 (0.47) KMT2ANPC1RAB9APOLBALDH1A1
SCHEMBL13536499 0.75 MAPT (0.60) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL30767874 0.74 PTGS2 (0.59) KMT2ANPC1RAB9APOLBMAPK1
SCHEMBL30767872 0.74 NPC1 (0.62) KMT2ANPC1RAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4317162-B1 1,3-BENZODIOXOLANE-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF XIAN XINTONG PHARMACEUTICAL RES CO LTD (CN) 2026-02-04 EP disclosed
US-20240059694-A1 COMPOUND CONTAINING 1,3-BENZODIOXOL STRUCTURE AND PREPARATION METHOD AND USE THEREOF XI'AN XINTONG PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2024-02-22 US disclosed
EP-4317162-A1 1,3-BENZODIOXOLANE-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Xi'An Xintong Pharmaceutical Research Co., Ltd. (CN) 2024-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059694-A1 COMPOUND CONTAINING 1,3-BENZODIOXOL STRUCTURE AND PREPARATION METHOD AND USE THEREOF BTK, JAK3, JAK1 KMT2A 2508/4885NPC1 4807/4885RAB9A 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.